The intermediary metabolism in prostate cancer: new targets for an old disease

被引:0
|
作者
Fritz, V [1 ]
Benfodda, Z. [1 ]
Henriquet, C. [1 ]
Hure, S. [1 ]
Fajas, L. [1 ]
机构
[1] Univ Montpellier 1, INSERM,CRLC, IRCM,U896, Metab & Canc Lab, F-34298 Montpellier, France
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S27 / S27
页数:1
相关论文
共 50 条
  • [21] PROSTATE CANCER AND BONE METABOLISM: NEW HORIZONS
    Di Francesco, Simona
    Tenaglia, Raffaele L.
    PROGRESS IN NUTRITION, 2014, 16 (02): : 90 - 93
  • [22] Metabolism - New Therapeutic Targets for Inflammatory Bowel Disease
    Kaser, Arthur
    DRUG RESEARCH, 2021, 71 : S11 - S12
  • [23] Lipid metabolism and metabolic disease: defining new targets
    Cohn, Jeffrey S.
    CURRENT OPINION IN LIPIDOLOGY, 2007, 18 (03) : 237 - 239
  • [24] From cancer metabolism to new biomarkers and drug targets
    Chiaradonna, F.
    Moresco, R. M.
    Airoldi, C.
    Gaglio, D.
    Palorini, R.
    Nicotra, F.
    Messa, C.
    Alberghina, L.
    BIOTECHNOLOGY ADVANCES, 2012, 30 (01) : 30 - 51
  • [25] Cancer Metabolism: New Validated Targets for Drug Discovery
    Sotgia, Federica
    Martinez-Outschoorn, Ubaldo E.
    Lisanti, Michael P.
    ONCOTARGET, 2013, 4 (08) : 1309 - 1316
  • [26] A new era in prostate cancer therapy: new targets and novel therapeutics
    Deborah A. Bradley
    Maha Hussain
    Cora N. Sternberg
    Targeted Oncology, 2008, 3 : 31 - 39
  • [27] A new era in prostate cancer therapy: new targets and novel therapeutics
    Bradley, Deborah A.
    Hussain, Maha
    Sternberg, Cora N.
    TARGETED ONCOLOGY, 2008, 3 (01) : 31 - 39
  • [28] Developmental Therapeutics in Metastatic Prostate Cancer: New Targets and New Strategies
    Zhang, Jingsong
    Chadha, Juskaran S.
    CANCERS, 2024, 16 (17)
  • [29] Metformin and Prostate Cancer: a New Role for an Old Drug
    Jessica Whitburn
    Claire M. Edwards
    Prasanna Sooriakumaran
    Current Urology Reports, 2017, 18
  • [30] Abiraterone in Prostate Cancer: A New Angle to an Old Problem
    Stein, Mark N.
    Goodin, Susan
    DiPaola, Robert S.
    CLINICAL CANCER RESEARCH, 2012, 18 (07) : 1848 - 1854